Consequently, mutations in PTEN in melanoma reduce this inhibition and allow for high AKT1 levels, with AKT1 playing a major role in metabolic alterations, resistance to treatment, and melanoma invasiveness [5]. The gene discussed is AKT1; the disease is melanoma.